Article
Liver endothelium promotes HER3-mediated cell survival in KRAS wild-type and mutant colorectal cancer cells
2021-07-26
Abstract excerpt
<title>Abstract</title> <p>We previously showed that human epidermal growth factor receptor 3 (HER3, also known as ERBB3) is a key mediator in liver endothelial cell (EC) promoting colorectal cancer (CRC) growth and chemoresistance, and suggested HER3-targeted therapy as a strategy for treating patients with metastatic CRC (mCRC) in the liver. Meanwhile, <italic>KRAS</italic> mutations occur in 40–50% of mCRC and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 391d9936-7361-56d2-b8ca-e333f8854dc0
- DOI
- 10.21203/rs.3.rs-745208/v1
